Heart of England NHS Foundation Trust

Birmingham, West Midlands B9 5SS

0 studies enrolling now · 2 studies all time

What they study most

Clostridium Difficile Infection, Heterozygous Familial Hypercholesterolemia

Studies at this site

• Clostridium Difficile Vaccine Efficacy Trial — Completed
• A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia — Completed